Fig. 1From: Changes in type 2 innate lymphoid cells and serum cytokines in sublingual immunotherapy in pediatric patients with allergic rhinitisAfter completing the 1- and 2-year treatment period, the significant downregulation of ILC2 frequency in PBMCs from AR donor. *P < 0.05, #P > 0.05. ILC2, type 2 innate lymphoid cells; PBMCs, peripheral blood mononuclear cells; AR, allergic rhinitisBack to article page